Acute Kidney Injury (AKI) Disease Treatment Market Size, Share, Opportunities, And Trends By Diagnosis (Urine Tests, Blood Tests, Glomerular Filtration Rate (GFR), Imaging Tests, Kidney Biopsy), By Treatment (Dialysis, RenalGuard Therapy, Treatment For Symptoms And Complications), And Geography - Forecasts From 2019 To 2024

Published: Mar 2020 | Report Code:  KSI061612284 | Pages:  96

The Acute Kidney Injury (AKI) Disease Treatment market was valued at US$29.612 billion in 2019 and is expected to grow at a CAGR of 1.09% over the forecast period to reach a market size of US$31.600 billion in 2025. The major drivers driving the growth of the global acute kidney injury (AKI) disease treatment market include growing elderly population, the prevalence of chronic diseases, and a growing number of acute care admissions and emergency department admissions leading to ICU admission. North America and Europe are expected to hold a significant market share due to the high disease prevalence and other chronic disease prevalence which may lead to the acute kidney disease while the Asia Pacific with Japan, having the maximum geriatric population in the world is expected to be the fastest growing. In addition, rising health awareness among people, especially in the developing countries will lead to frequent check-ups, emanating the market growth owing to early disease detection followed by treatment during the forecast period and beyond.
Major industry players profiled as part of the report are Exponential Biotherapies, Inc., NIKKISO AMERICA, INC., AM-Pharma, RenalGuard Solutions, Inc., Angion Biomedica Corp., Thrasos Therapeutics Inc., AtoxBio, and Sentien Biotechnologies, Inc.
The acute kidney injury (AKI) disease treatment market has been analyzed through following segments:
By Diagnosis
  • Urine Tests
  • Blood Tests
  • Glomerular Filtration Rate (GFR)
  • Imaging Tests
  • Kidney Biopsy
By Type of RRT
  • Continuous
  • Intermittent
By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Others